Skip to main content
. Author manuscript; available in PMC: 2012 Oct 15.
Published in final edited form as: J Immunol. 2011 Sep 14;187(8):4219–4228. doi: 10.4049/jimmunol.1100826

Table 1.

IFN-γ-independent tumor rejection occurs at extraocular sites but is excluded from the eye

Host Anterior Chamber Subcutaneous
C57BL/6 Rejected (15/15) Rejected (10/10)
IFN-γ KO Not Rejected (20/20) Rejected (22/25)
SCID Not Rejected (10/10) Not Rejected (9/10)
Nude Not Rejected (10/10) Not Rejected (10/10)

Ad5E1 clone 2.1 tumor cells (5 × 104) were injected in the AC or SC. Tumor growth was observed three times/ week. Results shown above were recorded on day 30 post tumor transplantation.